MEG3 and non-small cell lung carcinoma: Upregulation of MEG3 improves the sensitivity of DDP-resistant NSCLC cells to DDP treatment via inhibiting cell proliferation and inducing cell apoptosis modulated by the miR-21-5p/SRY-box transcription factor 7 (SOX7) axis [97].